A Phase 4 Multicenter Observational Study to Evaluate the Effectiveness of Patisiran in Patients with Polyneuropathy of Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with a V122I or T60A Mutation
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Observational
Locations
Outpatient CTRC
University of Colorado Hospital
Study ID
Protocol Number: 19-3061
More information available at ClinicalTrials.gov: NCT04201418
Categories
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers